Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex
PMA-S includes submission for pathogen-reduced cryoprecipitate-poor plasma CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that…
CIAM Complexity: The Real Cost of Manual Identity Management
Fovia AI to Showcase Universal AI Viewer and Seamless Reporting Integrations at Radiology Reimagined Exhibit, RSNA 2025
FG Gold, AFC and Afreximbank Reach Financial Close on US$330 Million Senior Debt Financing for Baomahun Gold Project
China Chunlai Announces 2025 Annual Results
USDKG launching: $50M Gold-backed Stablecoin in the Kyrgyz Republic